PUNE, India, September 2, 2016 /PRNewswire/ --
The objective of Global Prenatal, Maternal & Carrier Diagnostic Market Analysis to 2021 report is to provide an overview of the various technologies being employed for detecting genetic diseases in embryos, fetuses and newborns. The various chapters describe common pregnancy disorders, numerical chromosome disorders and structural chromosome disorders, single gene disorders inherited by fetuses, newborns and embryos. The report also analyzes the specifics pertaining to financial and business strategy, current products on the market and pipeline products.
Complete report on Prenatal, Maternal & Carrier Diagnostic Market spreads across 390 pages, analysed 114 major companies and provides 260 figures and tables is now available at http://www.rnrmarketresearch.com/global-prenatal-maternal-carrier-diagnostic-market-analysis-to-2021-market-report.html.
The global prenatal and maternal diagnostic test market is assessed with respect to: Fetal Ultrasound, Prenatal MRI Screening, Carrier Screening Tests, Maternal Serum Screening Tests, Noninvasive Prenatal Tests (NIPTs) using cffDNA, NIPTs by Product, Prenatal Diagnostic Invasive Tests, Newborn Screening for Genetic Diseases, Newborn Screening Market by Technology, Preimplantation Screening/Diagnosis (PGS/PGD)
Fetal Ultrasound Screening Market
Today, ultrasound is used on average five times per pregnancy before delivery. The fetal ultrasound screening market generated revenues of about $x million in 2014 with the potential to earn $x million in 2021, growing at a CAGR of x%. Fetal MRI prenatal screening is performed rarely, only when the ultrasound screening provides an ambiguous result and to detect suspected central nervous system (CNS) disorders in the fetus during the second trimester. The fetal MRI segment had generated estimated revenue of $x million in 2014 with a potential to earn $x million in 2021.
Maternal Serum Testing Market
The global maternal serum test market was worth $x million in 2014 and is forecast to grow and reach $x million by 2021. The market consists of test methods for: Pregnancy-associated plasma protein (PAPP-A), Alpha-fetoprotein (AFP), Human chorionic gonadotropin (hCG), Estriol, Inhibin-A
Order a copy of this prenatal screening market research at http://www.rnrmarketresearch.com/contacts/purchase?rname=681504.
Noninvasive Prenatal Test Market
Noninvasive prenatal tests (NIPTs) are the future of prenatal screening and have shown signs of surpassing the traditional maternal serum test revenues by earning about $x million in 2014. With a CAGR of x%, this market is forecast to reach $x million in 2021.
Newborn Screening Market
Newborn screening is an accepted national health policy in about 52 countries. Mass spectrometry has become the standard technique for newborn screening. Using this technique, medical technologists are capable of screening as many as 30 metabolic disorders from a single sample of blood. The global market for newborn screening has been valued at $x million in 2014 and it will be worth about $x million by 2021.
Preimplantation Genetic Diagnosis Market
Preimplantation genetic diagnosis (PGD) has been in practice for more than twenty years in about 60 countries globally. PGD testing is performed to identify genetic defects in embryos. The tests are usually performed in cases of a known genetic defect, in late age pregnancy, or in patients with a history of repeated miscarriages. PCR, FISH, CGH, and SNP analysis are some of the most common techniques used, and PCR is the most widely used technology. The global market for PGD was worth about $x million in 2014 and this has been predicted to enlarge and reach $x million in 2021.
Emerging trends in associated markets are also analysed in order to give the reader a comprehensive overview of how prenatal and maternal diagnostic testing is affected by Molecular Diagnostics Market, Liquid Biopsy Market, Personalized Medicine Diagnostics Market as well as In vitro Diagnostics (IVD) Market.
Browse complete table of contents and companies profiles in Global Prenatal, Maternal & Carrier Diagnostic Market Analysis to 2021.
Explorer other reports on In Vitro Diagnostics (IVD) at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd.
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
SOURCE RnR Market Research